Hayward, CA - IMPAX Laboratories, Inc. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for generic versions of Xanax XR, (Alprazolam) 0. Pharmacia and Upjohn markets Xanax XR for the management of anxiety disorder or the short-term relief of symptoms of anxiety. IMPAX’ Global Pharmaceuticals division plans to launch the product soon. Drug Discovery Online | VertMarkets, Inc. read more

Technorati Tags: drug, anxiety, impax, xanax, xr, , anxiety disorder news